A major French healthcare group with a prominent place in the national private healthcare market is currently assessing the possible divestment of its psychiatric and mental health division, together with associated clinics, as part of a process of corporate restructuring. The business in question is valued at between 180 and 230 million euros.
To this end, we solicit the submission of proposals or communications of potential interest in purchasing the business.
Further information will be provided in response to an initial contact request.

European multinational corporation with a prominent position in the biomedical technologies market is pursuing an investment project in Brazil with the objective of achieving significant growth in terms of turnover. This investment project is primarily directed at acquiring companies with locally established production plants as part of a project of horizontal integration. The company is thus interested in proposals involving both consolidated and start-up businesses working in the sector of cardiovascular pathology treatment technologies, or in neighboring and/or complementary sectors.